Biography
I am a Cancer Biologist specializing in molecular oncology, cellular stress pathways, and small-molecule drug mechanism profiling. I completed my Ph.D. in Biological Sciences (CSIR NET JRF/SRF rank holder – AIR 64) with a specialization in Cancer Biology at the Sunandan Divatia School of Science, NMIMS University, where my research focused on deregulated signaling mechanisms and the Integrated Stress Response (ATF4/CHOP axis) in cervical cancer. I hold an M.Sc. in Biotechnology from the Institute of Science, University of Mumbai, and a B.Sc. in Biotechnology from Vartak College. I have extensive technical expertise across cell culture, molecular assays, flow cytometry, biochemical profiling, and quantitative data analysis.
Research Areas
To understand the molecular and cellular mechanisms underlying regional heterogeneity and neuronal resilience in Parkinson’s disease using post-mortem brain tissues and advanced imaging techniques.
Peer-Reviewed Publications
- Pathak, S. O., & Manohar, S. M. (2025). ONC201 (Dordaviprone) Induces Integrated Stress Response and Death inCervical Cancer Cells. Biomolecules, 15(4), 463. Impact Factor: 5.6
- Pathak, S. O., et al. ONC201 (dordaviprone/TIC10) variably modulates autophagy response in HPV-positive cervical cancer cell lines in a CLPP-independent manner. Journal of Biochemical and Molecular Toxicology. Under Revision | IF: 3.5
- Das, S., Kompala, J., Laney, K., Pathak, S., Nayar, R., Khurana, S., Ghezzi, A., Karthik, L., & Banerjee, A. G. (2026). Emodin-induced cell cycle arrest: A promising approach for cancer therapy. Medicine International, 6(4), 328.
- Pathak, S. O., & Manohar, S. M. (2023). Molecular milieu of autophagy in cervical cancer and its therapeutic implications. Current Cancer Drug Targets, 23. Impact Factor: 2.5
